September 25, 2019
Sequana Medical enrolls first patient testing alfapump for liver cirrhosis-caused ascites
Belgian Sequana Medical has enrolled the first patient in the North American pivotal study of the alfapump for the treatment of recurrent and refractory ascites due to liver cirrhosis.